Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 306, Issue 9, 2014, Pages

  Kitzman, Dalane W ^a   Nicklas, Barbara ^a   Kraus, William E ^c   Lyles, Mary F ^a   Eggebeen, Joel ^a   Morgan, Timothy M ^b   Haykowsky, Mark ^d  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aging; Exercise; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; CAPILLARY; CLINICAL ARTICLE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUSCLE CELL; MYOPATHY; NEEDLE BIOPSY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKELETAL MUSCLE ABNORMALITY;

AGING; EXERCISE; HEART FAILURE;

AGED; CAPILLARIES; CASE-CONTROL STUDIES; EXERCISE; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; MALE; MICROCIRCULATION; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; STROKE VOLUME;

EID: 84900559283     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00004.2014     Document Type: Article

References (72)

1. Andersen P, Henriksson J. Capillary supply of the quadriceps femoris muscle of man: adaptive response to exercise. J Physiol 270: 677-690, 1977.
2. Bhella PS, Prasad A, Heinicke K, Hastings JL, Arbab-Zadeh A, Adams-Huet B, Pacini EL, Shibata S, Palmer MD, Newcomer BR, Levine BD. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail 13: 1296-1304, 2011.
3. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, Kass DA. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 114: 2138-2147, 2006.
4. Borlaug BA, Nishimura RA, Sorajja P, Lam CSP, Redfield MM. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 3: 588-595, 2010.
5. Borlaug BA, Olson TP, Lam CSP, Flood KS, Lerman A, Johnson BD, Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 56: 845-854, 2010.
6. Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C, Piepoli M, Fini M, Rosano GM. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 54: 919-927, 2009.
7. Cittadini A, Saldamarco L, Marra AM, Arcopinto M, Carlomagno G, Imbriaco M, Del Forno D, Vigorito C, Merola B, Oliviero U, Fazio S, Saccá L. Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. J Clin Endocrinol Metab 94: 3329-3336, 2009.
8. Coen PM, Jubrias SA, Distefano G, Amati F, Mackey DC, Glynn NW, Manini TM, Wohlgemuth SE, Leeuwenburgh C, Cummings SR, Newman AB, Ferrucci L, Toledo FGS, Shankland E, Conley KE, Goodpaster BH. Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults. J Gerontol A Bio Sci Med Sci 68: 447-455, 2013.
9. Coggan AR, Spina RJ, King DS. Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. J Gerontol 47: B71-B76, 1992.
10. Davies KJ, Donovan CM, Refino CJ, Brooks GA, Packer L, Dallman PR. Distinguishing effects of anemia and muscle iron deficiency on exercise bioenergetics in the rat. Am J Physiol Endocrinol Metab 246: E535-E543, 1984.
11. Downing J, Balady GJ. The role of exercise training in heart failure. J Am Coll Cardiol 58: 561-569, 2011.
12. Drexler H, Riede J, Munzel T, Konig H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 85: 1751-1759, 1992.
13. Duscha BD, Annex BH, Green HJ, Pippen AM, Kraus WE. Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure. J Am Coll Cardiol 39: 1170-1174, 2002.
14. Duscha BD, Annex BH, Keteyian SJ, Green HJ, Sullivan MJ, Samsa GP, Brawner CA, Schachat FH, Kraus WE. Differences in skeletal muscle between men and women with chronic heart failure. J Appl Physiol 90: 280-286, 2001.
15. Duscha BD, Kraus WE, Keteyian SJ, Sullivan MJ, Green HJ, Schachat FH, Pippen AM, Brawner CA, Blank JM, Annex BH. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol 33: 1956-1963, 1999.
16. Duscha BD, Robbins JL, Jones WS, Kraus WE, Lye RJ, Sanders JM, Allen JD, Regensteiner JG, Hiatt WR, Annex BH. Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients. Arterioscler Thromb Vasc Biol 31: 2742-2748, 2011.
17. Edelmann F, Aldo investigators-DHF. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the ALDO-DHF randomized controlled trial. JAMA 309: 781-791, 2013.
18. Franssen F, Wouters E, Schols A. The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases. Clin Nutr 21: 1-14, 2002.
19. 2+ in single intact muscle fibres from transgenic mice. J Physiol 552: 833-844, 2003.
20. Guyatt GH, Sullivan M, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LD. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132: 919-923, 1985.
21. Hambrecht R, Fiehn E, Yu J, Niebauer J, Weigl C, Hilbrich L, Adams V, Riede U, Schuler G. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 29: 1067-1073, 1997.
22. Haykowsky M, Kouba EJ, Brubaker PH, Nicklas BJ, Eggebeen J, Kitzman DW. Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol 113: 1211-1216, 2014.
23. Haykowsky MJ, Brubaker PH, Morgan TM, Kritchevsky SB, Eggebeen J, Kitzman DW. Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass. J Gerontol A Biol Sci Med Sci 68: 968-975, 2013.
24. Haykowsky MJ, Brubaker PH, Stewart KP, Morgan TM, Eggebeen J, Kitzman DW. Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol 60: 120-128, 2012.
25. Haykowsky MJ, Herrington DM, Brubaker PH, Morgan TM, Hundley WG, Kitzman DW. Relationship of flow mediated arterial; dilation and exercise capacity in older patients with heart failure and preserved ejection fraction. J Gerontol A Biol Sci Med Sci 68: 161-167, 2013.
26. Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol 58: 265-274, 2011.
27. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56: 831-838, 1984.
28. Ingjer F. Effects of endurance training on muscle fibre ATP-ase activity, capillary supply and mitochondrial content in man. J Physiol 294: 419-432, 1979.
29. John JM, Haykowsky MJ, Brubaker P, Stewart K, Kitzman DW. Decreased let ventricular distensibility in response to postural change in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol 299: H883-H889, 2010.
30. Katz SD, Maskin C, Jondeau G, Cocke T, Berkowitz R, LeJemtel T. Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure. J Appl Physiol 88: 2138-2142, 2000.
31. Keteyian SJ, Duscha BD, Brawner CA, Green HJ, Marks CRC, Schachat FH, Annex BH, Kraus WE. Differential effects of exercise training in men and women with chronic heart failure. Am Heart J 145: 912-918, 2003.
32. Kitzman DW, Hundley WG, Brubaker P, Stewart K, Little WC. A randomized, controlled, double-blinded trial of enalapril in older patients with heart failure and preserved ejection fraction; effects on exercise tolerance, and arterial distensibility. Circ Heart Fail 3: 477-485, 2010.
33. Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, Marino EK, Lyles M, Cushman M, Enright PL; Cardiovascular Health Study Research Group. Importance of heart failure with preserved systolic function in patients > or > 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 87: 413-419, 2001.
34. Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan M. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 17: 1065-1072, 1991.
35. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288: 2144-2150, 2002.
36. Kitzman DW, Brubaker PH, Herrington DM, Morgan TM, Stewart KP, Hundley WG, Abdelhamed A, Haykowsky MJ. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. J Am Coll Cardiol 62: 584-592, 2013.
37. Kitzman DW, Brubaker PH, Morgan TM, Stewart KP, Little WC. Exercise training in older patients with heart failure and preserved ejection fraction. Circ Heart Fail 3: 659-667, 2010.
38. Kleinbaum DG, Kupper LL, Nizam A, Muller KE. Applied Regression Analysis and Other Multivariable Methods. Belmont, CA: Thomson Brooks/Cole, 2008, p. 198-202.
39. Larsen A, Lindal S, Aukrust P, Toft I, Aarsland T, Dickstein K. Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity. Int J Cardiol 83: 25-32, 2002.
40. Larsson L, Sjodin B, Karlsson J. Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22-65 years. Acta Physiol Scand 103: 31-39, 1978.
41. Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM. Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 56: 855-863, 2010.
42. Magnusson G, Kaijser L, Rong H, Isberg B, Sylven C, Saltin B. Exercise capacity in heart failure patients: relative importance of heart and skeletal muscle. Clin Physiol 16: 183-195, 1996.
43. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85: 1364-1373, 1992.
44. Marburger CT, Brubaker PH, Pollock WE, Morgan TM, Kitzman DW. Reproducibility of cardiopulmonary exercise testing in elderly heart failure patients. Am J Cardiol 82: 905-909, 1998.
45. Massie BM, Simonini A, Sahgal P, Wells L, Dudley GA. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol 27: 140-145, 1996.
46. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A; I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359: 2456-2467, 2008.
47. Maurer MS, Schulze PC. Exercise intolerance in heart failure with preserved ejection fraction: shifting focus from the heart to peripheral skeletal muscle. J Am Coll Cardiol 60: 129-131, 2012.
48. Mettauer B, Zoll J, Sanchez H, Lampert E, Ribera F, Veksler V, Bigard X, Mateo P, Epailly E, Lonsdorfer J, Ventura-Clapier R. Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol 38: 947-954, 2001.
49. Middlekauff HR. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 3: 537-546, 2010.
50. Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 110: 558-565, 2004.
51. Nicklas B, Leng I, Delbono O, Kitzman DW, Marsh A, Hundley WG, Lyles M, O'Rourke KS, Annex BH, Kraus WE. Relationship of physical function to vastus lateralis capillary density and metabolic enzyme activity in elderly men and women. Aging Clin Exper Res 20: 302-309, 2008.
52. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355: 251-259, 2006.
53. Poole DC, Hirai DM, Copp SW, Musch TI. Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. Am J Physiol Heart Circ Physiol 302: H1050-H1063, 2012.
54. Puntawangkoon C, Kitzman D, Kritchevsky S, Hamilton C, Nicklas B, Leng X, Brubaker P, Hundley WG. Reduced peripheral arterial blood flow with preserved cardiac output during submaximal bicycle exercise in elderly heart failure. J Cardiovasc Mag Reson 11: 48, 2009.
55. Redfield M, Chen H, Borlaug B, Semigran M, Lee K, Lewis G, LeWinter M, Rouleau J, Bull D, Mann D, Deswal A, Stevenson L, Givertz M, Ofili E, O'Conner C, Felker G, Goldsmith S, Bart B, McNulty S, Ibarra J, Lin G, Oh J, Patel M, Kim R, Tracy R, Velazquez E, Anstrom K, Hernandez A, Mascette A, Braunwald E; RELAX Trial. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309: 1268-1277, 2013.
56. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney R. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333: 1190-1195, 1995.
57. Rossiter HB. Exercise: kinetic considerations for gas exchange. Compr Physiol 1: 203-244, 2011.
58. Schaufelberger M, Andersson G, Eriksson BO, Grimby G, Held P, Swedberg K. Skeletal muscle changes in patients with chronic heart failure before and after treatment with enalapril. Eur Heart J 17: 1678-1685, 1996.
59. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 20: 301-306, 1992.
60. Scott JM, Haykowsky MJ, Eggebeen J, Morgan TM, Brubaker PH, Kitzman DW. Reliability of peak exercise testing in patients with heart failure with preserved ejection fraction. Am J Cardiol 110: 1809-1813, 2012.
61. Simonini A, Long CS, Dudley GA, Yue P, McElhinny J, Massie BM. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res 79: 128-136, 1996.
62. Stehle JR Jr, Leng X, Kitzman DW, Nicklas BJ, Kritchevsky SB, High KP. LPS binding protein (LBP), a surrogate marker of microbial translocation is associated with physical function in healthy older adults. J Gerontol Med Sci 67: 1212-1218, 2012.
63. Stuart CA, McCurry MP, Marino A, South MA, Howell MEA, Layne AS, Ramsey MW, Stone MH. Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness. J Clin Endocrinol Metab 98: 2027-2036, 2013.
64. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81: 518-527, 1990.
65. Sullivan MJ, Green HJ, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity. Circulation 84: 1597-1607, 1991.
66. Sullivan MJ, Duscha BD, Klitgaard H, Kraus WE, Cobb F, Saltin B. Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure. Med Sci Sports Exerc 29: 1997.
67. Toth M, Matthews DE, Ades PA, Tischler MD, Van Buren P, Previs M, LeWinter MM. Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity. Am J Physiol Endocrinol Metab 288: E685-E692, 2005.
68. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a populationbased cohort. J Am Coll Cardiol 33: 1948-1955, 1999.
69. Ventura-Clapier R, Mettauer B, Bigard X. Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc Res 73: 10-18, 2007.
70. Vescovo G, Serafini F, Facchin L, Tenderini P, Carraro U, Dalla Libera L, Catani C, Ambrosio GB. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart 76: 337-343, 1996.
71. Vogiatzis I, Zakynthinos SG. The physiological basis of rehabilitation in chronic heart and lung disease. J Appl Physiol 115: 16-21, 2013.
72. Williams A, Selig S, Hare D, Hayes A, Krum H, Patterson J, Geerling R, Toia D, Carey MF. Reduced exercise tolerance in CHF may be related to factors other than impaired skeletal muscle oxidative capacity. J Card Fail 10: 141-148, 2004.